Horrillo has anti-doping 'administrative error'

Rabobank's Pedro Horrillo found himself in a touch of trouble during an anti-doping control after the ‘Brabantse Pijl’. Horrillo, who had a Therapeutic Use Exemption (TUE) for asthma medication, had apparently switched to a new medication not covered by his TUE. Horrillo had an exemption for two drugs: Pulmicort (active ingredient: Budesonide) and Serevent (active ingredient: Salmeterol).

However, earlier in the year, his physician had advised him to change to a new aerosol, Symbicort. This medication has the same effect as two aerosols together, and his doctor saw no need to apply for a new TUE with the International Cycling Federation UCI.

Thank you for reading 5 articles in the past 30 days*

Join now for unlimited access

Enjoy your first month for just £1 / $1 / €1

*Read any 5 articles for free in each 30-day period, this automatically resets

After your trial you will be billed £4.99 $7.99 €5.99 per month, cancel anytime. Or sign up for one year for just £49 $79 €59

Join now for unlimited access

Try your first month for just £1 / $1 / €1